Answers are grounded in this paper and cite their sources.
Cardiopulmonary exercise testing is a valuable, reproducible tool for the diagnosis, risk stratification, and monitoring of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Cardiopulmonary exercise testing allows for a comprehensive assessment of the mechanism of exercise limitation in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Competitive pathophysiologic mechanisms may affect the clinical interpretation of cardiopulmonary disease as they relate to dyspnea, leg fatigue, and exercise intolerance.
No takes yet. Share an insight, caveat, or question.
Coulis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: